Industry Research Reports

Home > Reports > Medical Devices & Consumables > Drug Closed System Transmission - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Drug Closed System Transmission - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-02-19

Pages: 126 Pages

Report ld: 2529814

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Closed System Transfer Devices (CSTDs) are specialized medical devices designed to provide a closed and secure system for the handling, preparation, administration, and disposal of hazardous drugs, particularly in settings such as hospitals, pharmacies, and clinics. These devices are engineered to minimize the risk of exposure to hazardous medications for healthcare workers, patients, and the environment.

The global market for Drug Closed System Transmission was estimated to be worth US$ 1269 million in 2023 and is forecast to a readjusted size of US$ 1870.2 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030

Drug Closed System Transmission Market Size

M= millions and B=billions

The Drug Closed System Transmission market focuses on providing specialized devices and solutions for the safe handling and administration of hazardous drugs in healthcare settings. These devices are designed to minimize the risk of exposure to hazardous medications for healthcare workers, patients, and the environment.

The global Drug Closed System Transmission market has been witnessing growth driven by increasing awareness about the risks associated with handling hazardous drugs, stringent regulations for occupational safety, and the growing adoption of closed system transfer devices in healthcare facilities.

Factors contributing to the growth of the global Drug Closed System Transmission market may include:
Implementation of Occupational Safety Standards: Regulatory bodies and healthcare organizations are increasingly recognizing the importance of protecting healthcare workers from exposure to hazardous drugs, leading to the adoption of stricter safety standards and guidelines.

Growing Focus on Patient Safety: Healthcare facilities are prioritizing patient safety by implementing closed system transfer devices to minimize the risks associated with the administration of hazardous medications.

Increasing Incidence of Cancer and Other Chronic Diseases: The rising prevalence of cancer and chronic diseases necessitates the safe handling and administration of chemotherapy drugs and other hazardous medications, thereby driving the demand for closed system transfer devices.

Technological Advancements: Continuous advancements in closed system transfer devices, such as improved compatibility with various medical components and enhanced performance, contribute to market growth.

Market Players and Competition: Several companies are actively involved in the development and supply of closed system transfer devices, resulting in increased competition and a wider range of options for healthcare facilities.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Closed System Transmission, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drug Closed System Transmission by region & country, by Type, and by Application.

The Drug Closed System Transmission market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Closed System Transmission.

Market Segmentation

Report Metric
Details
Report Title
Drug Closed System Transmission - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1870.2 million
CAGR(2024-2030)
5.7%
Market Size Available for Years
2019-2030
Global Drug Closed System Transmission Companies Covered
Equashield, BD Medical, Teva Medical, ICU Medical, Corvida Medical, B. Braun, Carmel Pharma, Yukon Medical, JMS North America, Tevadaptor, ChemoLock
Global Drug Closed System Transmission Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Closed System Transmission Market, Segment by Type
Closed Vial Access Device

Closed Syringe Safety Device

Closed Bag/Line Access Device
Global Drug Closed System Transmission Market, Segment by Application
Hospital

Clinic

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Closed System Transmission manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Drug Closed System Transmission in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Drug Closed System Transmission in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Drug Closed System Transmission Product Introduction
    1.2 Global Drug Closed System Transmission Market Size Forecast
        1.2.1 Global Drug Closed System Transmission Sales Value (2019-2030)
        1.2.2 Global Drug Closed System Transmission Sales Volume (2019-2030)
        1.2.3 Global Drug Closed System Transmission Sales Price (2019-2030)
    1.3 Drug Closed System Transmission Market Trends & Drivers
        1.3.1 Drug Closed System Transmission Industry Trends
        1.3.2 Drug Closed System Transmission Market Drivers & Opportunity
        1.3.3 Drug Closed System Transmission Market Challenges
        1.3.4 Drug Closed System Transmission Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Drug Closed System Transmission Players Revenue Ranking (2023)
    2.2 Global Drug Closed System Transmission Revenue by Company (2019-2024)
    2.3 Global Drug Closed System Transmission Players Sales Volume Ranking (2023)
    2.4 Global Drug Closed System Transmission Sales Volume by Company Players (2019-2024)
    2.5 Global Drug Closed System Transmission Average Price by Company (2019-2024)
    2.6 Key Manufacturers Drug Closed System Transmission Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Drug Closed System Transmission Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Drug Closed System Transmission
    2.9 Drug Closed System Transmission Market Competitive Analysis
        2.9.1 Drug Closed System Transmission Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Drug Closed System Transmission Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Closed System Transmission as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Closed Vial Access Device
        3.1.2 Closed Syringe Safety Device
        3.1.3 Closed Bag/Line Access Device
    3.2 Global Drug Closed System Transmission Sales Value by Type
        3.2.1 Global Drug Closed System Transmission Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Drug Closed System Transmission Sales Value, by Type (2019-2030)
        3.2.3 Global Drug Closed System Transmission Sales Value, by Type (%) (2019-2030)
    3.3 Global Drug Closed System Transmission Sales Volume by Type
        3.3.1 Global Drug Closed System Transmission Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Drug Closed System Transmission Sales Volume, by Type (2019-2030)
        3.3.3 Global Drug Closed System Transmission Sales Volume, by Type (%) (2019-2030)
    3.4 Global Drug Closed System Transmission Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Other
    4.2 Global Drug Closed System Transmission Sales Value by Application
        4.2.1 Global Drug Closed System Transmission Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Drug Closed System Transmission Sales Value, by Application (2019-2030)
        4.2.3 Global Drug Closed System Transmission Sales Value, by Application (%) (2019-2030)
    4.3 Global Drug Closed System Transmission Sales Volume by Application
        4.3.1 Global Drug Closed System Transmission Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Drug Closed System Transmission Sales Volume, by Application (2019-2030)
        4.3.3 Global Drug Closed System Transmission Sales Volume, by Application (%) (2019-2030)
    4.4 Global Drug Closed System Transmission Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Drug Closed System Transmission Sales Value by Region
        5.1.1 Global Drug Closed System Transmission Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Drug Closed System Transmission Sales Value by Region (2019-2024)
        5.1.3 Global Drug Closed System Transmission Sales Value by Region (2025-2030)
        5.1.4 Global Drug Closed System Transmission Sales Value by Region (%), (2019-2030)
    5.2 Global Drug Closed System Transmission Sales Volume by Region
        5.2.1 Global Drug Closed System Transmission Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Drug Closed System Transmission Sales Volume by Region (2019-2024)
        5.2.3 Global Drug Closed System Transmission Sales Volume by Region (2025-2030)
        5.2.4 Global Drug Closed System Transmission Sales Volume by Region (%), (2019-2030)
    5.3 Global Drug Closed System Transmission Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Drug Closed System Transmission Sales Value, 2019-2030
        5.4.2 North America Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Drug Closed System Transmission Sales Value, 2019-2030
        5.5.2 Europe Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Drug Closed System Transmission Sales Value, 2019-2030
        5.6.2 Asia Pacific Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Drug Closed System Transmission Sales Value, 2019-2030
        5.7.2 South America Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Drug Closed System Transmission Sales Value, 2019-2030
        5.8.2 Middle East & Africa Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Drug Closed System Transmission Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Drug Closed System Transmission Sales Value
        6.2.1 Key Countries/Regions Drug Closed System Transmission Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Drug Closed System Transmission Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Drug Closed System Transmission Sales Value, 2019-2030
        6.3.2 United States Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Drug Closed System Transmission Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Drug Closed System Transmission Sales Value, 2019-2030
        6.4.2 Europe Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Drug Closed System Transmission Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Drug Closed System Transmission Sales Value, 2019-2030
        6.5.2 China Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Drug Closed System Transmission Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Drug Closed System Transmission Sales Value, 2019-2030
        6.6.2 Japan Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Drug Closed System Transmission Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Drug Closed System Transmission Sales Value, 2019-2030
        6.7.2 South Korea Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Drug Closed System Transmission Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Drug Closed System Transmission Sales Value, 2019-2030
        6.8.2 Southeast Asia Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Drug Closed System Transmission Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Drug Closed System Transmission Sales Value, 2019-2030
        6.9.2 India Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Drug Closed System Transmission Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Equashield
        7.1.1 Equashield Company Information
        7.1.2 Equashield Introduction and Business Overview
        7.1.3 Equashield Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Equashield Drug Closed System Transmission Product Offerings
        7.1.5 Equashield Recent Development
    7.2 BD Medical
        7.2.1 BD Medical Company Information
        7.2.2 BD Medical Introduction and Business Overview
        7.2.3 BD Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 BD Medical Drug Closed System Transmission Product Offerings
        7.2.5 BD Medical Recent Development
    7.3 Teva Medical
        7.3.1 Teva Medical Company Information
        7.3.2 Teva Medical Introduction and Business Overview
        7.3.3 Teva Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Teva Medical Drug Closed System Transmission Product Offerings
        7.3.5 Teva Medical Recent Development
    7.4 ICU Medical
        7.4.1 ICU Medical Company Information
        7.4.2 ICU Medical Introduction and Business Overview
        7.4.3 ICU Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 ICU Medical Drug Closed System Transmission Product Offerings
        7.4.5 ICU Medical Recent Development
    7.5 Corvida Medical
        7.5.1 Corvida Medical Company Information
        7.5.2 Corvida Medical Introduction and Business Overview
        7.5.3 Corvida Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Corvida Medical Drug Closed System Transmission Product Offerings
        7.5.5 Corvida Medical Recent Development
    7.6 B. Braun
        7.6.1 B. Braun Company Information
        7.6.2 B. Braun Introduction and Business Overview
        7.6.3 B. Braun Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 B. Braun Drug Closed System Transmission Product Offerings
        7.6.5 B. Braun Recent Development
    7.7 Carmel Pharma
        7.7.1 Carmel Pharma Company Information
        7.7.2 Carmel Pharma Introduction and Business Overview
        7.7.3 Carmel Pharma Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Carmel Pharma Drug Closed System Transmission Product Offerings
        7.7.5 Carmel Pharma Recent Development
    7.8 Yukon Medical
        7.8.1 Yukon Medical Company Information
        7.8.2 Yukon Medical Introduction and Business Overview
        7.8.3 Yukon Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Yukon Medical Drug Closed System Transmission Product Offerings
        7.8.5 Yukon Medical Recent Development
    7.9 JMS North America
        7.9.1 JMS North America Company Information
        7.9.2 JMS North America Introduction and Business Overview
        7.9.3 JMS North America Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 JMS North America Drug Closed System Transmission Product Offerings
        7.9.5 JMS North America Recent Development
    7.10 Tevadaptor
        7.10.1 Tevadaptor Company Information
        7.10.2 Tevadaptor Introduction and Business Overview
        7.10.3 Tevadaptor Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Tevadaptor Drug Closed System Transmission Product Offerings
        7.10.5 Tevadaptor Recent Development
    7.11 ChemoLock
        7.11.1 ChemoLock Company Information
        7.11.2 ChemoLock Introduction and Business Overview
        7.11.3 ChemoLock Drug Closed System Transmission Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 ChemoLock Drug Closed System Transmission Product Offerings
        7.11.5 ChemoLock Recent Development

 8 Industry Chain Analysis
    8.1 Drug Closed System Transmission Industrial Chain
    8.2 Drug Closed System Transmission Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Drug Closed System Transmission Sales Model
        8.5.2 Sales Channel
        8.5.3 Drug Closed System Transmission Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Drug Closed System Transmission Market Trends
    Table 2. Drug Closed System Transmission Market Drivers & Opportunity
    Table 3. Drug Closed System Transmission Market Challenges
    Table 4. Drug Closed System Transmission Market Restraints
    Table 5. Global Drug Closed System Transmission Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Drug Closed System Transmission Revenue Market Share by Company (2019-2024)
    Table 7. Global Drug Closed System Transmission Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Drug Closed System Transmission Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Drug Closed System Transmission Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Drug Closed System Transmission Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Drug Closed System Transmission Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Drug Closed System Transmission
    Table 13. Global Drug Closed System Transmission Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Closed System Transmission as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Drug Closed System Transmission Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Drug Closed System Transmission Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Drug Closed System Transmission Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Drug Closed System Transmission Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Drug Closed System Transmission Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Drug Closed System Transmission Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Drug Closed System Transmission Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Drug Closed System Transmission Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Drug Closed System Transmission Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Drug Closed System Transmission Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Drug Closed System Transmission Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Drug Closed System Transmission Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Drug Closed System Transmission Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Drug Closed System Transmission Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Drug Closed System Transmission Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Drug Closed System Transmission Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Drug Closed System Transmission Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Drug Closed System Transmission Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Drug Closed System Transmission Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Drug Closed System Transmission Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Drug Closed System Transmission Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Drug Closed System Transmission Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Drug Closed System Transmission Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Drug Closed System Transmission Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Drug Closed System Transmission Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Drug Closed System Transmission Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Drug Closed System Transmission Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Drug Closed System Transmission Sales Value by Region (2019-2024) & (%)
    Table 44. Global Drug Closed System Transmission Sales Value by Region (2025-2030) & (%)
    Table 45. Global Drug Closed System Transmission Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Drug Closed System Transmission Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Drug Closed System Transmission Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Drug Closed System Transmission Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Drug Closed System Transmission Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Drug Closed System Transmission Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Drug Closed System Transmission Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Drug Closed System Transmission Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Drug Closed System Transmission Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Drug Closed System Transmission Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Drug Closed System Transmission Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Drug Closed System Transmission Sales Volume, (2025-2030) & (K Units)
    Table 57. Equashield Company Information
    Table 58. Equashield Introduction and Business Overview
    Table 59. Equashield Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Equashield Drug Closed System Transmission Product Offerings
    Table 61. Equashield Recent Development
    Table 62. BD Medical Company Information
    Table 63. BD Medical Introduction and Business Overview
    Table 64. BD Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. BD Medical Drug Closed System Transmission Product Offerings
    Table 66. BD Medical Recent Development
    Table 67. Teva Medical Company Information
    Table 68. Teva Medical Introduction and Business Overview
    Table 69. Teva Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Teva Medical Drug Closed System Transmission Product Offerings
    Table 71. Teva Medical Recent Development
    Table 72. ICU Medical Company Information
    Table 73. ICU Medical Introduction and Business Overview
    Table 74. ICU Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. ICU Medical Drug Closed System Transmission Product Offerings
    Table 76. ICU Medical Recent Development
    Table 77. Corvida Medical Company Information
    Table 78. Corvida Medical Introduction and Business Overview
    Table 79. Corvida Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Corvida Medical Drug Closed System Transmission Product Offerings
    Table 81. Corvida Medical Recent Development
    Table 82. B. Braun Company Information
    Table 83. B. Braun Introduction and Business Overview
    Table 84. B. Braun Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. B. Braun Drug Closed System Transmission Product Offerings
    Table 86. B. Braun Recent Development
    Table 87. Carmel Pharma Company Information
    Table 88. Carmel Pharma Introduction and Business Overview
    Table 89. Carmel Pharma Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Carmel Pharma Drug Closed System Transmission Product Offerings
    Table 91. Carmel Pharma Recent Development
    Table 92. Yukon Medical Company Information
    Table 93. Yukon Medical Introduction and Business Overview
    Table 94. Yukon Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Yukon Medical Drug Closed System Transmission Product Offerings
    Table 96. Yukon Medical Recent Development
    Table 97. JMS North America Company Information
    Table 98. JMS North America Introduction and Business Overview
    Table 99. JMS North America Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. JMS North America Drug Closed System Transmission Product Offerings
    Table 101. JMS North America Recent Development
    Table 102. Tevadaptor Company Information
    Table 103. Tevadaptor Introduction and Business Overview
    Table 104. Tevadaptor Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Tevadaptor Drug Closed System Transmission Product Offerings
    Table 106. Tevadaptor Recent Development
    Table 107. ChemoLock Company Information
    Table 108. ChemoLock Introduction and Business Overview
    Table 109. ChemoLock Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. ChemoLock Drug Closed System Transmission Product Offerings
    Table 111. ChemoLock Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Drug Closed System Transmission Downstream Customers
    Table 115. Drug Closed System Transmission Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Closed System Transmission Product Picture
    Figure 2. Global Drug Closed System Transmission Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drug Closed System Transmission Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Drug Closed System Transmission Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Drug Closed System Transmission Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Drug Closed System Transmission Report Years Considered
    Figure 7. Global Drug Closed System Transmission Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Drug Closed System Transmission Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Closed System Transmission Revenue in 2023
    Figure 10. Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Closed Vial Access Device Picture
    Figure 12. Closed Syringe Safety Device Picture
    Figure 13. Closed Bag/Line Access Device Picture
    Figure 14. Global Drug Closed System Transmission Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Drug Closed System Transmission Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Drug Closed System Transmission Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Drug Closed System Transmission Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Drug Closed System Transmission Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Product Picture of Other
    Figure 22. Global Drug Closed System Transmission Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Drug Closed System Transmission Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Drug Closed System Transmission Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Drug Closed System Transmission Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Drug Closed System Transmission Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Drug Closed System Transmission Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Drug Closed System Transmission Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Drug Closed System Transmission Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Drug Closed System Transmission Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Drug Closed System Transmission Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Drug Closed System Transmission Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Drug Closed System Transmission Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Drug Closed System Transmission Sales Volume (%), (2019-2030)
    Figure 39. United States Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Drug Closed System Transmission Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Drug Closed System Transmission Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Drug Closed System Transmission Sales Value by Application (%), 2023 VS 2030
    Figure 60. Drug Closed System Transmission Industrial Chain
    Figure 61. Drug Closed System Transmission Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Closed System Transfer Devices (CSTDs) are specialized medical devices designed to provide a closed and secure system for the handling, preparation, administration, and disposal of hazardous drugs, particularly in settings such as hospitals, pharmacies, and clinics. These devices are engineered to minimize the risk of exposure to hazardous medications for healthcare workers, patients, and the environment.

The global market for Drug Closed System Transmission was estimated to be worth US$ 1269 million in 2023 and is forecast to a readjusted size of US$ 1870.2 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030

The Drug Closed System Transmission market focuses on providing specialized devices and solutions for the safe handling and administration of hazardous drugs in healthcare settings. These devices are designed to minimize the risk of exposure to hazardous medications for healthcare workers, patients, and the environment.

The global Drug Closed System Transmission market has been witnessing growth driven by increasing awareness about the risks associated with handling hazardous drugs, stringent regulations for occupational safety, and the growing adoption of closed system transfer devices in healthcare facilities.

Factors contributing to the growth of the global Drug Closed System Transmission market may include:
Implementation of Occupational Safety Standards: Regulatory bodies and healthcare organizations are increasingly recognizing the importance of protecting healthcare workers from exposure to hazardous drugs, leading to the adoption of stricter safety standards and guidelines.

Growing Focus on Patient Safety: Healthcare facilities are prioritizing patient safety by implementing closed system transfer devices to minimize the risks associated with the administration of hazardous medications.

Increasing Incidence of Cancer and Other Chronic Diseases: The rising prevalence of cancer and chronic diseases necessitates the safe handling and administration of chemotherapy drugs and other hazardous medications, thereby driving the demand for closed system transfer devices.

Technological Advancements: Continuous advancements in closed system transfer devices, such as improved compatibility with various medical components and enhanced performance, contribute to market growth.

Market Players and Competition: Several companies are actively involved in the development and supply of closed system transfer devices, resulting in increased competition and a wider range of options for healthcare facilities.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Closed System Transmission, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drug Closed System Transmission by region & country, by Type, and by Application.

The Drug Closed System Transmission market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Closed System Transmission.

Market Segmentation

Industry: Medical Devices & Consumables

Published: 2024-02-19

Pages: 126 Pages

Report ld: 2529814

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License